INX IMCD N.V.

Shareholders IMCD N.V. adopt all resolutions at AGM

Shareholders IMCD N.V. adopt all resolutions at AGM

Rotterdam, The Netherlands (25 April 2025) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, announces that all resolutions proposed to the shareholders at the Annual General Meeting of Shareholders (AGM) held today were adopted.

The resolutions included the adoption of the financial statements for the year 2024 and the proposal of a cash dividend of EUR 2.15 per share.

The dividend calendar is as follows:

  • 29 April 2025                Ex-dividend date
  • 30 April 2025                Dividend record date
  • 6 May 2025                  Dividend payment date



The 2024 Remuneration Report received support from shareholders with 97.78% of votes casted in favor of the report.

Further details of the AGM, including all voting results, are available in the Investors Relations’ section of the Company’s website .

- xxx-

About IMCD

IMCD, based in Rotterdam, The Netherlands, is a leading global partner for the distribution and formulation of speciality chemicals and ingredients. IMCD is an expert solutions provider and adds sustainable value to the supply chain. Every day professionals focus on providing the best service through commercial and operational excellence. The company is mindful of the role they play in creating a better planet for all and formulates with consciousness and executes with care, to address business challenges of tomorrow, in partnership and transparency.

In 2024, with over 5,100 employees, IMCD realised revenues of EUR 4,728 million. IMCD N.V.’s shares are traded at Euronext Amsterdam (symbol: IMCD) and included in the Dutch ESG AEX index, as one of 25 companies within the AEX and AMX indices demonstrating best ESG practices.

For further information, please visit    

Media contact

Muriel Werlé

Corporate Communications Director

4

Investor relations contact

Tosca Holtland

Head of Investor Relations

3

Attachment



EN
25/04/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IMCD N.V.

 PRESS RELEASE

IMCD to acquire TECOM Ingredients to strengthen its offering in the fo...

IMCD to acquire TECOM Ingredients to strengthen its offering in the food & nutrition market in Spain Rotterdam, The Netherlands (16 May 2025) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, has signed an agreement to acquire 100% of the shares in TECOM Ingredients S.A. (“TECOM”). Founded in 1996 and headquartered in Molins de Rei, near Barcelona, Spain, TECOM is a recognised distributor of ingredients and additives to the food industry. The company is a trusted partner for customers active in the food...

Quirijn Mulder ... (+2)
  • Quirijn Mulder
  • Stijn Demeester

IMCD/Good start, valuation attractive/BUY

After surprisingly good numbers 1Q25, we believe there is more upside but 1Q has the easiest comp. Also, trade tariffs might disturb the distribution chain of chemicals. Overall, we modestly adjust our estimates for FY25-27, but we do not change our BUY rating. IMCD is in excellent shape in our view – the company's track record in growth, value enhancement and M&A continues, and its strong asset light model is intact. The share price fall since December has led to 18% lower multiples, suggesting...

IMCD NV: 1 director

A director at IMCD NV bought 840 shares at 118.690EUR and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing...

Guy Sips ... (+6)
  • Guy Sips
  • Kristof Samoy
  • Michiel Declercq
  • Thibault Leneeuw
  • Thomas Couvreur
  • Wim Lewi

Morning Notes : AALB NA, AD NA, ARCAD NA, SMAR BB, WKL NA, AZE BB, CTP...

: AALB NA, AD NA, ARCAD NA, SMAR BB, WKL NA, AZE BB, CTPNV NA, IMCD NA

Thibault Leneeuw
  • Thibault Leneeuw

IMCD Short-term revisions in light of the uncertainty

In this note we adjust our numbers to reflect the increased uncertainty which results in lower organic growth for FY25 and FY26. While the Gross Profit margin remained robust, OpEx was well above expectations across all regions. Due to these dynamics we lower our forecasted FY25 EBITA by 6% to € 548m. Furthermore, we dive into the divergence with Azelis as this stood out in 1Q25. Our adjustments result in a lower valuation of € 147 per share. Given the upside we maintain our Accumulate recommend...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch